Amal Bouziane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amal Bouziane has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Oum Keltoum Ennibi
Department of Periodontology, Research Laboratory in Oral Biology and Biotechnology, Faculty of Dental Medicine Mohammed V University in Rabat Rabat Morocco
13 shared publications - Latifa Benrachadi
Université Mohammed V, faculté de médecine dentaire, département de parodontologie, Rabat, Maroc
5 shared publications - Redouane Abouqal
Biostatistics Laboratory, Clinical Epidemiology Research. Faculty of Medicine and Pharmacy Mohammed V University in Rabat Rabat Morocco
5 shared publications Fatima Zaoui
3 shared publications- Fatna Laidi
Oral Biomechanics and Biotechnology Research Unit, Faculty of Dental Medicine, University Mohammed V, Rabat, Morocco :
3 shared publications Amina Lakhdar
Department of Obstetrics and Gynecology, Ibn Sina University Hospital, Rabat, Morocco
2 shared publications
Latest Publications
- 17 March 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (8) , 2421-2429
Grade C Periodontitis in Young Adults: A Subcategory or a Distinct Disease Entity?
Objective: To assess the correspondence between periodontitis categories defined by 1999 AAP and 2018 AAP/EFP classification systems, and to characterize clinical features within Grade C periodontitis. Methods: A cross‐sectional study was conducted on patients with periodontitis. Participants were examined and classified according to both classifications. Comparative analyses between aggressive (AgP) and chronic (CP) periodontitis within Grade C included age, bone loss patterns, clinical attachment loss, furcation involvement, and tooth mobility. The association between classifications was illustrated using alluvial diagrams and analyzed using V Cramer's coefficient. Results: Among 427 patients, Grade A and B periodontitis corresponded to CP. Grade C included cases previously classified as AgP as well as severe CP. Correspondence between periodontitis types and grades showed a significant association p < 0.001. The strength of this association was large V = 0.63 95% CI [0.55, 0.76]. Although grouped under the same grade, significant differences were observed between AgP and CP. AgP cases were younger and had more frequent, preferential involvement of incisors and first molars, vertical or combined bone loss, advanced furcation defect, and hypermobility. Conclusion: While the 2018 classification has advanced diagnostic criteria for periodontal diseases, future revision of the Grade C category could enhance diagnostic specificity by integrating phenotypic variations.
- 17 March 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (8) , 2421-2429
Grade C Periodontitis in Young Adults: A Subcategory or a Distinct Disease Entity?
Objective: To assess the correspondence between periodontitis categories defined by 1999 AAP and 2018 AAP/EFP classification systems, and to characterize clinical features within Grade C periodontitis. Methods: A cross‐sectional study was conducted on patients with periodontitis. Participants were examined and classified according to both classifications. Comparative analyses between aggressive (AgP) and chronic (CP) periodontitis within Grade C included age, bone loss patterns, clinical attachment loss, furcation involvement, and tooth mobility. The association between classifications was illustrated using alluvial diagrams and analyzed using V Cramer's coefficient. Results: Among 427 patients, Grade A and B periodontitis corresponded to CP. Grade C included cases previously classified as AgP as well as severe CP. Correspondence between periodontitis types and grades showed a significant association p < 0.001. The strength of this association was large V = 0.63 95% CI [0.55, 0.76]. Although grouped under the same grade, significant differences were observed between AgP and CP. AgP cases were younger and had more frequent, preferential involvement of incisors and first molars, vertical or combined bone loss, advanced furcation defect, and hypermobility. Conclusion: While the 2018 classification has advanced diagnostic criteria for periodontal diseases, future revision of the Grade C category could enhance diagnostic specificity by integrating phenotypic variations.
- 12 July 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (20) , 2637-2647
Efficacy of PD-1/PDL-1 inhibitors for ovarian cancer: a systematic review and network meta-analysis
Randomized controlled trials (RCTs) have assessed the efficacy of anti-programmed cell death 1 (PD- 1)/programmed cell death ligand 1 (PD-L1), alone or combined with other therapies, for ovarian cancer. However, the optimal strategy remains unclear. This study evaluated their effectiveness as monotherapy and in combination. We conducted a systematic review and Frequentist network meta-analysis (NMA) by searching PubMed, ScienceDirect, Web of Science, Scopus, Cochrane Library, and Clinicaltrials.gov databases. This analysis included RCTs comparing PD-L1/PD-1 inhibitors, alone or in combination with other therapies. Six studies involving 3,895 patients and eight treatment combinations were included. PD1/PDL1 inhibitors plus chemotherapy and PD1/PDL1 inhibitors plus ipilimumab showed the greatest progression-free survival (PFS) benefit (hazard ratio (HR) = 0.82, 95% confidence interval [CI]: 0.52-1.07; HR = 0.82, 95% CI:0.51-1.33) and overall survival (OS) (HR = 0.85, 95% CI:0.64-1.14; HR = 0.83, 95% CI:0.45-1.54). These combinations also improved overall response rates (ORR), especially with chemotherapy (OR = 3.06; 95% CI:1.42-6.60). Subgroup analysis suggested that PD-1/PD-L1 inhibitors plus chemotherapy provided the best PFS and OS in PD-L1-positive patients. Combining PD-1/PD-L1 inhibitors with chemotherapy or ipilimumab improved survival in ovarian cancer. However, PD-L1 expression may be a valuable biomarker for predicting the efficacy of PD-1/PD-L1 checkpoint inhibitors. This systematic review was preregistered in PROSPERO (CRD42022342057). Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD42022347967.
- 12 July 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (20) , 2637-2647
Efficacy of PD-1/PDL-1 inhibitors for ovarian cancer: a systematic review and network meta-analysis
Randomized controlled trials (RCTs) have assessed the efficacy of anti-programmed cell death 1 (PD- 1)/programmed cell death ligand 1 (PD-L1), alone or combined with other therapies, for ovarian cancer. However, the optimal strategy remains unclear. This study evaluated their effectiveness as monotherapy and in combination. We conducted a systematic review and Frequentist network meta-analysis (NMA) by searching PubMed, ScienceDirect, Web of Science, Scopus, Cochrane Library, and Clinicaltrials.gov databases. This analysis included RCTs comparing PD-L1/PD-1 inhibitors, alone or in combination with other therapies. Six studies involving 3,895 patients and eight treatment combinations were included. PD1/PDL1 inhibitors plus chemotherapy and PD1/PDL1 inhibitors plus ipilimumab showed the greatest progression-free survival (PFS) benefit (hazard ratio (HR) = 0.82, 95% confidence interval [CI]: 0.52-1.07; HR = 0.82, 95% CI:0.51-1.33) and overall survival (OS) (HR = 0.85, 95% CI:0.64-1.14; HR = 0.83, 95% CI:0.45-1.54). These combinations also improved overall response rates (ORR), especially with chemotherapy (OR = 3.06; 95% CI:1.42-6.60). Subgroup analysis suggested that PD-1/PD-L1 inhibitors plus chemotherapy provided the best PFS and OS in PD-L1-positive patients. Combining PD-1/PD-L1 inhibitors with chemotherapy or ipilimumab improved survival in ovarian cancer. However, PD-L1 expression may be a valuable biomarker for predicting the efficacy of PD-1/PD-L1 checkpoint inhibitors. This systematic review was preregistered in PROSPERO (CRD42022342057). Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD42022347967.
- Open Access
- 9 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71019
Antiseptics Prescription for the Prevention and Treatment of Periodontal Diseases: A Comprehensive Review
Background and Aims: Antiseptics have been widely used in periodontology and implantology as an adjunct to mechanical plaque control. The main objective of this review was to summarize the best evidence for the use of antiseptics in the prevention and treatment of periodontal and peri‐implant diseases. Methods: A comprehensive literature search was conducted across multiple databases, including Scopus, PubMed/Medline, Web of Science, and ScienceDirect. Keywords such as (Antiseptics OR mouthwashes) AND (gingivitis OR periodontitis OR peri‐implantitis OR mucositis) were used. Inclusion criteria included narrative or systematic reviews with or without meta‐analysis and clinical studies. In vitro, animal studies, and case reports were excluded. Results: Antiseptics, including chlorhexidine, essential oils, and povidone‐iodine, proved effective in reducing gingival inflammation and improving the plaque index. Other molecules, such as octenidine dihydrochloride, showed some effectiveness, although further studies are needed to expand their use. Conclusion: Antiseptics play a crucial role in improving periodontal health. Prescriptions should be tailored to therapeutic goals to ensure appropriate dosage and duration, while avoiding excessive use.
- 9 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71019
Open AccessAntiseptics Prescription for the Prevention and Treatment of Periodontal Diseases: A Comprehensive Review
Background and Aims: Antiseptics have been widely used in periodontology and implantology as an adjunct to mechanical plaque control. The main objective of this review was to summarize the best evidence for the use of antiseptics in the prevention and treatment of periodontal and peri‐implant diseases. Methods: A comprehensive literature search was conducted across multiple databases, including Scopus, PubMed/Medline, Web of Science, and ScienceDirect. Keywords such as (Antiseptics OR mouthwashes) AND (gingivitis OR periodontitis OR peri‐implantitis OR mucositis) were used. Inclusion criteria included narrative or systematic reviews with or without meta‐analysis and clinical studies. In vitro, animal studies, and case reports were excluded. Results: Antiseptics, including chlorhexidine, essential oils, and povidone‐iodine, proved effective in reducing gingival inflammation and improving the plaque index. Other molecules, such as octenidine dihydrochloride, showed some effectiveness, although further studies are needed to expand their use. Conclusion: Antiseptics play a crucial role in improving periodontal health. Prescriptions should be tailored to therapeutic goals to ensure appropriate dosage and duration, while avoiding excessive use.
- Open Access
qPCR Detection and Quantification of Aggregatibacter actinomycetemcomitans and Other Periodontal Pathogens in Saliva and Gingival Crevicular Fluid among Periodontitis Patients
Objective: The detection of special bacterial species in patients with periodontitis is considered useful for clinical diagnosis and treatment. The aim of this study was to investigate the presence of specific periopathogens and investigate whether there is a correlation between the results of different bacterial species in whole saliva and pooled subgingival plaque samples (healthy and diseased sites) from individuals with periodontitis and periodontally healthy subjects. Materials and methods: In total, 52 patients were recruited and divided into two groups: non-periodontitis and periodontitis patients. For each group, the following periodontal pathogens were detected using real-time polymerase chain reaction: A. actinomycetemcomitans JP2 clone, A. actinomycetemcomitans non JP2 clone, Porphyromonasgingivalis, and total eubacteria. Results: Higher levels of the various studied bacteria were present in both saliva and plaque samples from the periodontitis group in comparison to non-periodontitis subjects. There were significant differences in P. gingivalis and A. actinomycetemcomitans JP2 clones in the saliva of periodontitis patient compared to the control group. Subgingival plaque of diseased sites presented a significant and strong positive correlation between A. actinomycetemcomitans and P. gingivalis. In saliva samples, there was a significant positive correlation between A. actinomycetemcomitans JP2 clone and P. gingivalis (p ≤ 0.002). Conclusion: Quantifying and differentiating these periodontal species from subgingival plaque and saliva samples showed a good potential as diagnostic markers for periodontal disease. Regarding the prevalence of the studied bacteria, specifically A. actinomycetemcomitans JP2 clone, found in this work, and the high rate of susceptibility to periodontal species in Africa, future larger studies are recommended.
Open AccessqPCR Detection and Quantification of Aggregatibacter actinomycetemcomitans and Other Periodontal Pathogens in Saliva and Gingival Crevicular Fluid among Periodontitis Patients
Objective: The detection of special bacterial species in patients with periodontitis is considered useful for clinical diagnosis and treatment. The aim of this study was to investigate the presence of specific periopathogens and investigate whether there is a correlation between the results of different bacterial species in whole saliva and pooled subgingival plaque samples (healthy and diseased sites) from individuals with periodontitis and periodontally healthy subjects. Materials and methods: In total, 52 patients were recruited and divided into two groups: non-periodontitis and periodontitis patients. For each group, the following periodontal pathogens were detected using real-time polymerase chain reaction: A. actinomycetemcomitans JP2 clone, A. actinomycetemcomitans non JP2 clone, Porphyromonasgingivalis, and total eubacteria. Results: Higher levels of the various studied bacteria were present in both saliva and plaque samples from the periodontitis group in comparison to non-periodontitis subjects. There were significant differences in P. gingivalis and A. actinomycetemcomitans JP2 clones in the saliva of periodontitis patient compared to the control group. Subgingival plaque of diseased sites presented a significant and strong positive correlation between A. actinomycetemcomitans and P. gingivalis. In saliva samples, there was a significant positive correlation between A. actinomycetemcomitans JP2 clone and P. gingivalis (p ≤ 0.002). Conclusion: Quantifying and differentiating these periodontal species from subgingival plaque and saliva samples showed a good potential as diagnostic markers for periodontal disease. Regarding the prevalence of the studied bacteria, specifically A. actinomycetemcomitans JP2 clone, found in this work, and the high rate of susceptibility to periodontal species in Africa, future larger studies are recommended.
- Open Access
- 29 March 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 76, 103539
Fibrin sealant versus sutures in periodontal surgery: A systematic review
The aim of this systematic review was to assess the effectiveness of fibrin sealant compared to sutures in periodontal surgery. Five electronic databases (PubMed, Scopus, EBSCO, Cochrane and Web of Science) were screened from initiation to January 2021 for randomized controlled trials (RCTs) comparing fibrin sealant to sutures in periodontal surgery using this search equation: (Periodont* OR Periodontitis) AND (“fibrin tissue adhesive” OR “fibrin glue” OR “fibrin sealant” OR “fibrin sealant system” OR “fibrin adhesive system” OR “fibrin fibronectin sealant system”). Quality assessment of the included studies was performed using the revised tool to assess risk of bias in randomized trials (RoB 2). The level of evidence was evaluated using the GRADE tool. A total of 240 publications were found as search results in the screened databases. Four RCTs were included in this systematic review based on predetermined inclusion criteria. The trials were published between 1987 and 2014. All the RCTs compared fibrin sealant to sutures in periodontal surgery. The sample size included 101 patients. The overall risk of bias in this systematic review was at high risk in 75% of the studies, while 25% of the studies raised some concerns. The level of evidence evaluated using GRADE tool was very low. The current systematic review indicates a low level of evidence of the use of fibrin sealant as an alternative to sutures in periodontal practice. More interventional and multicentric studies should be conducted to support and confirm the results of the included studies.
- 29 March 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 76, 103539
Open AccessFibrin sealant versus sutures in periodontal surgery: A systematic review
The aim of this systematic review was to assess the effectiveness of fibrin sealant compared to sutures in periodontal surgery. Five electronic databases (PubMed, Scopus, EBSCO, Cochrane and Web of Science) were screened from initiation to January 2021 for randomized controlled trials (RCTs) comparing fibrin sealant to sutures in periodontal surgery using this search equation: (Periodont* OR Periodontitis) AND (“fibrin tissue adhesive” OR “fibrin glue” OR “fibrin sealant” OR “fibrin sealant system” OR “fibrin adhesive system” OR “fibrin fibronectin sealant system”). Quality assessment of the included studies was performed using the revised tool to assess risk of bias in randomized trials (RoB 2). The level of evidence was evaluated using the GRADE tool. A total of 240 publications were found as search results in the screened databases. Four RCTs were included in this systematic review based on predetermined inclusion criteria. The trials were published between 1987 and 2014. All the RCTs compared fibrin sealant to sutures in periodontal surgery. The sample size included 101 patients. The overall risk of bias in this systematic review was at high risk in 75% of the studies, while 25% of the studies raised some concerns. The level of evidence evaluated using GRADE tool was very low. The current systematic review indicates a low level of evidence of the use of fibrin sealant as an alternative to sutures in periodontal practice. More interventional and multicentric studies should be conducted to support and confirm the results of the included studies.
- Open Access
- 11 January 2022
- Published by Wiley in International Journal of Microbiology
- Vol. 2022, 1-8
Candida albicans and Candida dubliniensis in Periodontitis in Adolescents and Young Adults
Aim. This study aims to evaluate the association of Candida albicans and Candida dubliniensis with periodontitis in adolescents and young adults in a Moroccan population. Methods. 426 subjects aged between 12 and 25 years were recruited for the study. A pool of plaque sample was taken. Samples were cultured on Sabouraud Chloramphenicol medium at 37°C for 24–48 hours and then identified by the Vitek 2 YST system. Clinical data and presence of Candida albicans and Candida dubliniensis were analyzed using Jamovi (Version 1.8). Results. Candida albicans was observed in 25 subjects among 68 diseased patients (37%) and in 60 subjects among 358 healthy patients (17%). It can be reported that under normal yeast conditions, there is a statistically significant difference between these two groups ( ). Candida dubliniensis was more prevalent in periodontitis than in healthy subjects ( ). Regarding clinical variables, subgroups of periodontitis subjects showed significant statistical differences for periodontal probing depth, clinical attachment loss, and number of decayed teeth in advanced periodontitis in comparison with initial or mild periodontitis. The results also indicate that the presence of the two species of Candida is not related to gender or age ( ) nor related to the severity of the periodontal disease in this population. Conclusion. Within the limits of our study, Candida albicans is more frequently associated with periodontitis. The potential role of C. albicans in periodontitis pathogenesis is very complex. More studies on biofilm associated with different forms of periodontitis are necessary. It is also important to assess the coexistence of periodontitis and caries and the associated biofilms.
- 11 January 2022
- Published by Wiley in International Journal of Microbiology
- Vol. 2022, 1-8
Open AccessCandida albicans and Candida dubliniensis in Periodontitis in Adolescents and Young Adults
Aim. This study aims to evaluate the association of Candida albicans and Candida dubliniensis with periodontitis in adolescents and young adults in a Moroccan population. Methods. 426 subjects aged between 12 and 25 years were recruited for the study. A pool of plaque sample was taken. Samples were cultured on Sabouraud Chloramphenicol medium at 37°C for 24–48 hours and then identified by the Vitek 2 YST system. Clinical data and presence of Candida albicans and Candida dubliniensis were analyzed using Jamovi (Version 1.8). Results. Candida albicans was observed in 25 subjects among 68 diseased patients (37%) and in 60 subjects among 358 healthy patients (17%). It can be reported that under normal yeast conditions, there is a statistically significant difference between these two groups ( ). Candida dubliniensis was more prevalent in periodontitis than in healthy subjects ( ). Regarding clinical variables, subgroups of periodontitis subjects showed significant statistical differences for periodontal probing depth, clinical attachment loss, and number of decayed teeth in advanced periodontitis in comparison with initial or mild periodontitis. The results also indicate that the presence of the two species of Candida is not related to gender or age ( ) nor related to the severity of the periodontal disease in this population. Conclusion. Within the limits of our study, Candida albicans is more frequently associated with periodontitis. The potential role of C. albicans in periodontitis pathogenesis is very complex. More studies on biofilm associated with different forms of periodontitis are necessary. It is also important to assess the coexistence of periodontitis and caries and the associated biofilms.
- Open Access
- 1 January 2022
- Published by Wiley in International Journal of Dentistry
- Vol. 2022 (1) , 3664516
Salivary Biomarkers in Periodontitis Patients: A Pilot Study
Background and Objective. Periodontal disease is a chronic inflammatory condition, involving the destruction of both soft and hard tissues in the periodontal region. Advances in diagnostic research are moving toward methods whereby the periodontal risk can be identified and quantified by objective measures using specific inflammatory markers that can be correlated to the severity of the disease. The purpose of this study was to evaluate salivary concentrations of IL‐1β, IL‐6, MMP‐8, and IL‐10 in healthy and periodontitis patients and to assess the association between these biomarkers levels and clinical parameters in a Moroccan population. Materials and Methods. Forty subjects were included: 10 periodontally healthy subjects and 30 periodontitis patients. Periodontal examination and saliva sampling were performed in all patients. Levels of salivary cytokines including IL‐1β, IL‐6, MMP‐8, and IL‐10 were evaluated by a sandwich ELISA test kit. Data were analyzed by SPSS for Windows. Results. Regarding individual biomarkers, IL‐1β, IL‐6, and MMP‐8 levels were significantly higher in periodontitis patients (p ≤ 0.001, p < 0.05, respectively). The concentration of these proteins in saliva showed a significant association with gingival index and pocket depth measurements and may reflect the clinical status of healthy and diseased periodontium. However, no significant differences were observed for the IL‐10 component. Conclusion. IL‐1β and IL‐6 concentrations were statistically higher in periodontitis patients and may be used as potential tools in periodontitis diagnosis.
- 1 January 2022
- Published by Wiley in International Journal of Dentistry
- Vol. 2022 (1) , 3664516
Open AccessSalivary Biomarkers in Periodontitis Patients: A Pilot Study
Background and Objective. Periodontal disease is a chronic inflammatory condition, involving the destruction of both soft and hard tissues in the periodontal region. Advances in diagnostic research are moving toward methods whereby the periodontal risk can be identified and quantified by objective measures using specific inflammatory markers that can be correlated to the severity of the disease. The purpose of this study was to evaluate salivary concentrations of IL‐1β, IL‐6, MMP‐8, and IL‐10 in healthy and periodontitis patients and to assess the association between these biomarkers levels and clinical parameters in a Moroccan population. Materials and Methods. Forty subjects were included: 10 periodontally healthy subjects and 30 periodontitis patients. Periodontal examination and saliva sampling were performed in all patients. Levels of salivary cytokines including IL‐1β, IL‐6, MMP‐8, and IL‐10 were evaluated by a sandwich ELISA test kit. Data were analyzed by SPSS for Windows. Results. Regarding individual biomarkers, IL‐1β, IL‐6, and MMP‐8 levels were significantly higher in periodontitis patients (p ≤ 0.001, p < 0.05, respectively). The concentration of these proteins in saliva showed a significant association with gingival index and pocket depth measurements and may reflect the clinical status of healthy and diseased periodontium. However, no significant differences were observed for the IL‐10 component. Conclusion. IL‐1β and IL‐6 concentrations were statistically higher in periodontitis patients and may be used as potential tools in periodontitis diagnosis.
- Open Access
- 1 November 2021
- Published by Elsevier in Japanese Dental Science Review
- Vol. 57, 20-26
Etiology of aggressive periodontitis in individuals of African descent
- 1 November 2021
- Published by Elsevier in Japanese Dental Science Review
- Vol. 57, 20-26
Open AccessEtiology of aggressive periodontitis in individuals of African descent
- 3 February 2020
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 47 (4) , 406-428
Global prevalence of aggressive periodontitis: A systematic review and meta‐analysis
Aim: The prevalence of aggressive periodontitis (AgP) varies considerably between studies. The aim of this meta‐analysis was to estimate, throughout the world, the prevalence of this disease.Materials and Methods: Pubmed/Medline, Scopus, Science Direct, EBSCO and Cochrane library were systematically searched up to March 2018. Study selection criteria included cross‐sectional studies reporting prevalence of AgP in non‐specific population and permanent dentition. We assessed risk of bias using the Joanna Briggs Institute tool. A random effect meta‐analysis model was used to estimate the prevalence of AgP. Publication bias was assessed by Begg and Egger's tests and visual aspect of funnel plot.Results: A total of 33 articles were included. Pooled prevalence for AgP was 1.6% (95% CI 1.1–2.3). Higher pooled prevalence rates were reported in Africa (4.2%, 95% CI 2.0–7.1) and South America (4.0%, 95% CI 0.9–9.1) compared with Europe (0.1%, 95% CI 0.1–0.2). A pooled prevalence of 1.2%, 95% CI 0.5–2.2 was found in Asia and 0.8%, 95% CI 0.4–1.4 in North America. Heterogeneity between groups was statistically significant (Q statistic p < .001).Conclusions: A relatively high prevalence of AgP was found in Africa. However, the data support the weakness of the definition of this form of periodontal disease. Studies with less heterogeneity are needed to address accurately the prevalence of AgP.
- 3 February 2020
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 47 (4) , 406-428
Global prevalence of aggressive periodontitis: A systematic review and meta‐analysis
Aim: The prevalence of aggressive periodontitis (AgP) varies considerably between studies. The aim of this meta‐analysis was to estimate, throughout the world, the prevalence of this disease.Materials and Methods: Pubmed/Medline, Scopus, Science Direct, EBSCO and Cochrane library were systematically searched up to March 2018. Study selection criteria included cross‐sectional studies reporting prevalence of AgP in non‐specific population and permanent dentition. We assessed risk of bias using the Joanna Briggs Institute tool. A random effect meta‐analysis model was used to estimate the prevalence of AgP. Publication bias was assessed by Begg and Egger's tests and visual aspect of funnel plot.Results: A total of 33 articles were included. Pooled prevalence for AgP was 1.6% (95% CI 1.1–2.3). Higher pooled prevalence rates were reported in Africa (4.2%, 95% CI 2.0–7.1) and South America (4.0%, 95% CI 0.9–9.1) compared with Europe (0.1%, 95% CI 0.1–0.2). A pooled prevalence of 1.2%, 95% CI 0.5–2.2 was found in Asia and 0.8%, 95% CI 0.4–1.4 in North America. Heterogeneity between groups was statistically significant (Q statistic p < .001).Conclusions: A relatively high prevalence of AgP was found in Africa. However, the data support the weakness of the definition of this form of periodontal disease. Studies with less heterogeneity are needed to address accurately the prevalence of AgP.
- 16 January 2020
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 75 (4) , 807-826
Antimicrobial activity of honey in periodontal disease: a systematic review
Background: Honey has shown positive antimicrobial and anti-inflammatory actions in several dermatological studies; however, it is unclear if it could be effective in the treatment of periodontal disease.Objectives: To answer the question: Does honey have antimicrobial activity against periodontopathogens?Methods: Six electronic databases were screened from initiation to 31 January 2019 for randomized clinical trials (RCTs) and controlled in vitro studies exploring the antimicrobial effect of honey against periodontopathogens. Honey’s botanical origin, periopathogens that showed microbial susceptibility to honey, MICs, microbial growth conditions, control product and clinical follow-up were the main investigated outcomes. The risk of bias (RoB) of included RCTs was assessed using the Cochrane Collaboration RoB tool. The RoB of in vitro studies was evaluated based on the Sarkis-Onofre judgement model adapted to the context of honey.Results: A total of 1448 publications were found as search results in the screened databases. Sixteen eligible papers were included based on predetermined inclusion criteria. Retained studies included 5 RCTs and 11 in vitro controlled trials. Manuka and multifloral honeys were the most studied varieties. The tested honeys showed a significant antimicrobial action, with different MICs, against eight periopathogens. Four of the five RCTs showed a high RoB, while 4 of the 11 retained in vitro studies showed a medium RoB.Conclusions: Honey showed a significant antimicrobial activity against all targeted periopathogens. Additional experiments are required to explore the entire antimicrobial spectrum of honey towards all pathogens involved in periodontal disease.
- 16 January 2020
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 75 (4) , 807-826
Antimicrobial activity of honey in periodontal disease: a systematic review
Background: Honey has shown positive antimicrobial and anti-inflammatory actions in several dermatological studies; however, it is unclear if it could be effective in the treatment of periodontal disease.Objectives: To answer the question: Does honey have antimicrobial activity against periodontopathogens?Methods: Six electronic databases were screened from initiation to 31 January 2019 for randomized clinical trials (RCTs) and controlled in vitro studies exploring the antimicrobial effect of honey against periodontopathogens. Honey’s botanical origin, periopathogens that showed microbial susceptibility to honey, MICs, microbial growth conditions, control product and clinical follow-up were the main investigated outcomes. The risk of bias (RoB) of included RCTs was assessed using the Cochrane Collaboration RoB tool. The RoB of in vitro studies was evaluated based on the Sarkis-Onofre judgement model adapted to the context of honey.Results: A total of 1448 publications were found as search results in the screened databases. Sixteen eligible papers were included based on predetermined inclusion criteria. Retained studies included 5 RCTs and 11 in vitro controlled trials. Manuka and multifloral honeys were the most studied varieties. The tested honeys showed a significant antimicrobial action, with different MICs, against eight periopathogens. Four of the five RCTs showed a high RoB, while 4 of the 11 retained in vitro studies showed a medium RoB.Conclusions: Honey showed a significant antimicrobial activity against all targeted periopathogens. Additional experiments are required to explore the entire antimicrobial spectrum of honey towards all pathogens involved in periodontal disease.